More problems found in Chinese-made heart medications

August 6, 2018

Two more Chinese drugmakers have announced that a blood-pressure medication they exported to Taiwan contained a potentially cancer-causing impurity, a month after the same problem at another Chinese manufacturer prompted a global recall.

Tianyu Pharm and Rundu Pharma said batches of valsartan, an active ingredient widely used in medications for and , contained N-nitrosodimethylamine (NDMA), which is believed to potentially cause cancer through long-term use.

Tianyu Pharm made its announcement in a statement Monday to the Shenzhen exchange, where both companies are listed, while Rundu admitted the same in an exchange statement on Friday.

Shares of both companies plunged by the maximum daily limit of 10 percent on Monday.

Last month Europe's medical regulator issued an alert over supplies of valsartan produced by another company, Shanghai-listed Huahai Pharmaceutical, followed about a week later by a similar notice from the US Food and Drug Administration.

Huahai has since launched a global recall.

Tianyu Pharm said the problem was caught before its valsartan was distributed to end-users in Taiwan, while Rundu Pharma said its products made it onto the island's market but would be recalled.

China's government is struggling to shore up public confidence in the pharmaceutical sector following the revelation last month that a major Chinese manufacturer of rabies vaccines was found to have fabricated records and was ordered to cease production.

The government has said the suspect rabies vaccines did not enter the market, but the case has provoked unusually strong outrage online from consumers fed up with recurring product-safety scandals, particularly in the drug sector.

Explore further: Chinese firm recalls heart drug as US, EU raise concerns

Related Stories

Chinese firm recalls heart drug as US, EU raise concerns

July 18, 2018
The Chinese manufacturer of a widely used blood pressure medication said it had launched a global recall after US and European regulators warned of contamination by a cancer-causing impurity.

European regulator launches review of recalled heart drug

August 2, 2018
The European Medicines Agency (EMA) said Thursday it is conducting a review of the health effects on patients of a widely used blood pressure medication recalled around the world last month.

Affected by the valsartan heart drug recall? here's what to do

July 19, 2018
(HealthDay)—After the U.S. Food and Drug Administration announced last week that certain brands of blood pressure medicines contained a carcinogen and were being recalled, many patients may wonder what's next for their ...

FDA recalls heart medication valsartan, citing cancer concerns

July 17, 2018
The U.S. Food and Drug Administration issued a voluntary recall of several medications that contain the active ingredient valsartan, which is used to treat high blood pressure and heart failure.

India recalls vaccines made by tainted China firm

August 1, 2018
India has ordered an immediate recall of rabies vaccines made by a scandal-hit Chinese company, India's drug regulator said Wednesday, complaining it only found out about possible problems through media reports.

Chinese parents stage rare public protest over vaccine scare

July 30, 2018
About a dozen people held a rare protest outside China's Health Ministry to demand action over a vaccine scandal that has inflamed public fears over the safety of domestically produced drugs.

Recommended for you

Juul e-cigarettes pose addiction risk for young users, study finds

October 19, 2018
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by ...

Adding refined fiber to processed food could have negative health effects

October 19, 2018
Adding highly refined fiber to processed foods could have negative effects on human health, such as promoting liver cancer, according to a new study by researchers at Georgia State University and the University of Toledo.

Self-lubricating latex could boost condom use: study

October 17, 2018
A perpetually unctuous, self-lubricating latex developed by a team of scientists in Boston could boost the use of condoms, they reported Wednesday in the journal Royal Society Open Science.

How healthy will we be in 2040?

October 17, 2018
A new scientific study of forecasts and alternative scenarios for life expectancy and major causes of death in 2040 shows all countries are likely to experience at least a slight increase in lifespans. In contrast, one scenario ...

Adequate consumption of 'longevity' vitamins could prolong healthy aging, nutrition scientist says

October 16, 2018
A detailed new review of nutritional science argues that most American diets are deficient in a key class of vitamins and minerals that play previously unrecognized roles in promoting longevity and in staving off chronic ...

Study finds evidence of intergenerational transmission of trauma among ex-POWs from the Civil War

October 16, 2018
A trio of researchers affiliated with the National Bureau of Economic Research has found evidence that suggests men who were traumatized while POWs during the U.S. Civil War transmitted that trauma to their offspring—many ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.